Verisk Analytics (VRSK) is a data analytics powerhouse in the bio-tech and insurance markets. The company's performance has been oscillating lately, with many questioning whether the company has hit its peak or not. On one hand, several firms and investors such as
KLP Kapitalforvaltning AS, Seaport Research, and Osaic Holdings Inc. increased their investment in the company. This points to a positive outlook. Venues such as
Wall Street Consensus have also listed Verisk as a moderate buy. However, the company has reported mixed returns, lower Q3 revenue estimates, and slowed growth in Q3 which has affected the company's stock negatively. Verisk's decision to sell its
Marketing Solutions Unit to ActiveProspect, the termination of a $2.4 billion AccuLynx deal post FTC-review delay and the lowered 2025 revenue guidance concerns has left the market split in their opinion. Some see it as a refocus on core insurance analytics, pointing out active collaborations like Verisk's partnership with
Earnix for insurance compliance automation and with KYND for cyber data. On the other hand, it has led some investors such as Robeco and Perpetual to decrease their stakes citing concerns over revenue growth.
Verisk Analytics VRSK News Analytics from Tue, 10 Jun 2025 07:00:00 GMT to Sat, 10 Jan 2026 13:07:38 GMT -
Rating 3
- Innovation 6
- Information 8
- Rumor -2
